Aptose Biosciences Inc.
Compositions and methods for treating cancers

Last updated:

Abstract:

The present invention relates to compositions and methods for treating of cancer. In some embodiments, the invention relates to the use of agents that can modulate a component in the CDX2-KLF4 signaling pathway to treat myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), adult T-cell leukaemia (ATLL), lymphoma, gastric cancer, multiple myeloma, or combinations thereof, or a condition associated with abnormal activity of the CDX2-KLF4 signaling pathway.

Status:
Grant
Type:

Utility

Filling date:

20 Mar 2018

Issue date:

31 Aug 2021